US seeks injunction against Actavis unit
This article was originally published in Scrip
Executive Summary
The Iceland-based generics maker Actavisfaces a potentially serious problem with its Little Falls, New Jersey solid oral-dose facility (a site of Actavis Totowa) following a November 14th US complaint over adulterated and misbranded products.